The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Substance Abuse Therapeutics Market Research Report 2025
Synopsis
Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
The global Substance Abuse Therapeutics market was valued at US$ 17840 million in 2023 and is anticipated to reach US$ 27740 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Substance Abuse Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Substance Abuse Therapeutics.
Report Scope
The Substance Abuse Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Substance Abuse Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Substance Abuse Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Substance Abuse Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine.
The global Substance Abuse Therapeutics market was valued at US$ 17840 million in 2023 and is anticipated to reach US$ 27740 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Substance Abuse Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Substance Abuse Therapeutics.
Report Scope
The Substance Abuse Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Substance Abuse Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Substance Abuse Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Segment by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Segment by Application
Hospital & Clinics
Residential (non-hospital)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Substance Abuse Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Opioid Addiction
1.2.3 Tobacco/Nicotine Addiction
1.2.4 Alcohol Dependence
1.3 Market by Application
1.3.1 Global Substance Abuse Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Substance Abuse Therapeutics Market Perspective (2019-2030)
2.2 Substance Abuse Therapeutics Growth Trends by Region
2.2.1 Global Substance Abuse Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Substance Abuse Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Substance Abuse Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Substance Abuse Therapeutics Market Dynamics
2.3.1 Substance Abuse Therapeutics Industry Trends
2.3.2 Substance Abuse Therapeutics Market Drivers
2.3.3 Substance Abuse Therapeutics Market Challenges
2.3.4 Substance Abuse Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Substance Abuse Therapeutics Players by Revenue
3.1.1 Global Top Substance Abuse Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Substance Abuse Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Substance Abuse Therapeutics Revenue
3.4 Global Substance Abuse Therapeutics Market Concentration Ratio
3.4.1 Global Substance Abuse Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Substance Abuse Therapeutics Revenue in 2023
3.5 Substance Abuse Therapeutics Key Players Head office and Area Served
3.6 Key Players Substance Abuse Therapeutics Product Solution and Service
3.7 Date of Enter into Substance Abuse Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Substance Abuse Therapeutics Breakdown Data by Type
4.1 Global Substance Abuse Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Substance Abuse Therapeutics Forecasted Market Size by Type (2025-2030)
5 Substance Abuse Therapeutics Breakdown Data by Application
5.1 Global Substance Abuse Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Substance Abuse Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Substance Abuse Therapeutics Market Size (2019-2030)
6.2 North America Substance Abuse Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Substance Abuse Therapeutics Market Size by Country (2019-2024)
6.4 North America Substance Abuse Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Substance Abuse Therapeutics Market Size (2019-2030)
7.2 Europe Substance Abuse Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Substance Abuse Therapeutics Market Size by Country (2019-2024)
7.4 Europe Substance Abuse Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Substance Abuse Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Substance Abuse Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Substance Abuse Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Substance Abuse Therapeutics Market Size (2019-2030)
9.2 Latin America Substance Abuse Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Substance Abuse Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Substance Abuse Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Substance Abuse Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Substance Abuse Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Substance Abuse Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Detail
11.1.2 Indivior Business Overview
11.1.3 Indivior Substance Abuse Therapeutics Introduction
11.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.1.5 Indivior Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Substance Abuse Therapeutics Introduction
11.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Alkermes
11.3.1 Alkermes Company Detail
11.3.2 Alkermes Business Overview
11.3.3 Alkermes Substance Abuse Therapeutics Introduction
11.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.3.5 Alkermes Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Substance Abuse Therapeutics Introduction
11.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Substance Abuse Therapeutics Introduction
11.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.5.5 Mylan Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Substance Abuse Therapeutics Introduction
11.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.6.5 Cipla Recent Development
11.7 Glenmark
11.7.1 Glenmark Company Detail
11.7.2 Glenmark Business Overview
11.7.3 Glenmark Substance Abuse Therapeutics Introduction
11.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.7.5 Glenmark Recent Development
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Detail
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.8.5 Dr. Reddy's Laboratories Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Detail
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Introduction
11.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2019-2024)
11.9.5 Teva Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
